CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » NEWS

Oncology NEWS International. Vol. 4 No. 5
Pages: 1  2  3  
Next
 

Sibling BMT Matches on the Decline

May 1, 1995

WASHINGTON--As the size of the American family declines, the number of transplants from donors other than human leukocyte antigen (HLA) identical siblings can be expected to rise sharply in coming years, John A. Hansen, MD, said at a meeting on blood and marrow transplantation, sponsored by the Leukemia Society of America.

"As families get smaller, the average American has less than a 30% chance of finding an HLA match among his or her siblings," said Dr. Hansen, of the Fred Hutchinson Cancer Research Center and the University of Washington.

Dr. Hansen, along with Craig W. S. Howe, MD, PhD, CEO of the National Marrow Donor Program (NMDP), called for an expanded pool of donors to help provide matches for these patients.

Since the risk of acute graft-versus-host disease (GVHD) rises with the number of incompatible HLA loci, bone marrow transplant (BMT) specialists must look for ways to overcome inevitable mismatches and reduce the incidence and severity of GVHD.

An initial search of the NMDP registry will uncover an HLA-A, B, or DR identical match for 61% of transplant patients. At the Fred Hutchinson Cancer Research Center, higher resolution testing has shown that just 34% of patients will have at least one identical HLA-A, B, DRB1 donor, while the rest will have a donor with a minor mismatch in one antigen. Another 11% of patients will have a potential donor with at least one major mismatch.

A close match has significant implications for BMT outcomes. With a DRB1 match, the 5-year survival rate is 63%, Dr. Hansen said, but a mismatch offers a 5-year survival rate of only 37%. Moreover, a DRB1 mismatch results in more acute GVHD than do HLA-A or HLA-B mismatches.

In his presentation, Dr. Howe cited an analysis of transplants at 35 centers between 1988 and 1992. The study showed the following prognostic factors to be statistically significant in predicting a favorable outcome: a complete serological match, male donor sex, younger donor age, shorter disease duration, younger recipient age, and higher Karnofsky score.

Pages: 1  2  3  
Next
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Skin Lesions
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • New AUA Guidelines for Prostate Cancer Screening
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Genomics Studies Identify Testicular Cancer Risk Variants
  • Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
  • FDA Approves Erlotinib (Tarceva) as First-Line Lung Cancer Therapy for Certain Patients
Click here to subscribe to our newsletter


CancerNetwork on Facebook


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy